CARGO Therapeutics, Inc. Common Stock Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
0M
-
0M
0M
97M
21M
76M
-97M
2M
-98M
0M
-98M
139.67%
0M
-2M
0M
4M
0M
0M
-
0M
0M
35M
5M
29M
-35M
5M
-41M
0M
-41M
600.02%
35M
-5M
-33M
1M
-35M
0M
-
0M
0M
6M
2M
4M
-6M
0M
-6M
0M
-6M
600.02%
6M
0M
-6M
0M
-6M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
4Q2022
3Q2022
0M
-
0M
0M
35M
8M
27M
-35M
0M
-32M
0M
-32M
600.02%
35M
0M
-31M
1M
-32M
0M
-
0M
0M
29M
6M
22M
-29M
0M
-35M
0M
-35M
600.02%
29M
0M
-34M
1M
-35M
0M
-
0M
0M
11M
2M
9M
-11M
3M
-14M
0M
-14M
600.02%
11M
-3M
-11M
0M
-11M
0M
-
0M
0M
10M
2M
8M
-10M
1M
-12M
0M
-12M
600.02%
0M
-1M
0M
0M
0M